Therapeutic Advances in Medical Oncology (Jun 2017)

Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, . “A modified regimen of biweekly gemcitabine and -paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” https://doi.org/10.1177/1758834016676011

  • Daniel D Von Hoff,
  • Markus F Renschler

DOI
https://doi.org/10.1177/1758834017699772
Journal volume & issue
Vol. 9

Abstract

Read online

No abstracts available.